Evidence map›Paper›PMID 40018336›Full record

ReviewJournal of family & community medicine

Awareness of prostate cancer and its screening tests in men in the Middle East: A systematic review and meta-analysis.

Nawaf S A Mohamed, Joud M O Asfari, Samar M A Sambawa, Rima M D Aljurf, Kholoud A A Alsaygh, Assad M Arafah

Abstract readReview
In one paragraph

Review in Journal of family & community medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nawaf S A MohamedDepartment of Medicine, College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.
Joud M O AsfariDepartment of Medicine, College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.
Samar M A SambawaDepartment of Medicine, College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.
Rima M D AljurfDepartment of Medicine, College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.
Kholoud A A AlsayghDepartment of Medicine, College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.
Assad M ArafahDepartment of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is a significant health issue characterized by the uncontrolled growth of cells in the prostate gland primarily affecting men 50 years old or older. The aim of this research was to assess the level of knowledge and attitudes of men in the Middle East towards PCa. A comprehensive search strategy in major databases from the date of first publication on this topic to April 2024 was conducted of cross-sectional studies assessing the knowledge and attitudes of adult men in the Middle East toward PCa. Data on the study's methodology, participant characteristics, and outcomes related to the knowledge of PCa and attitudes towards PCa were extracted and analyzed using the comprehensive meta-analysis software. The Newcastle-Ottawa Scale was used for quality assessment. The meta-analysis of 26 studies revealed significant heterogeneity among studies, with an overall rate of previous education on PCa at 76.3% (95% confidence interval [CI]: 61.2%- 86.8%), but a much lower rate of education on PCa screening at 20.5% (95% CI: 7.2%-46.2%). Knowledge of PCa, its screening tools, symptoms, risk factors, and treatments, as well as attitudes towards PCa screening, varied widely, with knowledge rates of 50.5% for PCa, 32.3% for screening tools, 45.5% for symptoms, 49.4% for risk factors, and 58.4% for treatments. The rate of favorable attitude towards PCa screening was reported at 50.0% (95% CI: 36.7%-63.3%). The Middle East has some understanding of PCa but there is little knowledge of screening techniques, symptoms, risk factors, and treatments. To improve early detection and patient outcomes, comprehensive education and culturally sensitive communication strategies are necessary.

Indexed as

Attitudeknowledgemiddle eastprostate cancerscreening

Identifiers

PMID40018336
PMCPMC11864354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.